Category: NASDAQIONS

Evening pictures Ionis Pharmaceuticals (Nasdaq: ions(Amazon) announced Friday that its investigational treatment dondalorsen has achieved positive results in two late-stage trials for hereditary angioedema (HAE), a rare genetic disorder characterized by body swelling. Citing data from the phase III studies OASIS-HAE and OASISplus, the company Dundalorsen, an RNA-targeted treatment, reduced…